WAY-629

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameWAY-629

Drug Alias NameWAY-629

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2c (5-HT2c) receptor antagonists

TargetsSerotonin 2c (5-HT2c) receptor

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsObesity

ATC CodeN/A